相关实验视频
Updated: Sep 10, 2025

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
444
情绪障碍中的神经营养因子基因多态变异:试点研究
Ekaterina V Mikhalitskaya1, Natalya M Vyalova1, Diana Z Paderina1
1Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.
International journal of molecular sciences
|August 28, 2025
概括
像BDNF这样的神经营养因子基因的遗传变异与情感障碍有关. 特定的BDNF多态可能作为抑郁症的生物标志物,影响临床特征和治疗反应.
科学领域:
- 神经科学
- 遗传学
- 精神病学
背景情况:
- 神经缩因子调节神经元的过程,包括分化,神经生成,协同生成和可塑性.
- 神经营养因子的失调与情感障碍的病因有关.
研究的目的:
- 研究神经营养因子基因 (BDNF,NGF,NRG1) 和情感障碍之间的关系.
- 探索这些多形态与临床特征之间的关系,包括疾病严重程度和治疗反应.
主要方法:
- 病例对照研究涉及235名情绪障碍患者和187名健康对照患者.
- 使用SIGH-SAD,HARS和CGI尺度进行心理状态评估.
- 使用实时PCR对BDNF,NGF和NRG1基因的多态变异进行基因定型.
主要成果:
- 在BDNF基因中的rs7124442多态与情感障碍之间发现了显著的关联.
- 大多数研究的多态 (不包括BDNF的rs11030104) 显示与临床特征和治疗反应的关联或趋势.
结论:
- 研究的神经营养基因,特别是BDNF,显示出对抑郁症发病,临床表现和治疗结果的神经生物学标志物的潜力.
- 需要进一步的大规模,多元的族群研究来证实这些发现并克服研究的局限性.
相关概念视频
Human Genetics
716
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
716
Depressive Disorders: Etiology
165
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
165
Biological Causes of Schizophrenia
145
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
145
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Factors Affecting Illness
4.4K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K

